Pharm-Olam completes birch and grass pollen allergy studies

Saturday, February 01, 2014

Pharm-Olam was contracted to provide a full-service solution for two Phase II, dose escalation allergy studies that required a total of 500 patients in Europe. With two different allergy indications, Grass Pollen and Birch Pollen, these studies presented some unique challenges.

Pharm-Olam Expands into Israel

Monday, January 13, 2014

In our continued quest to reduce time and effort to bring medicines to market; Pharm-Olam is pleased to announce expansion into Israel. Pharm-Olam continues to look to increase its strategic footprint to offer our clients a greater choice to support their clinical trials. Incorporating Israel into your clinical trials offers you several benefits including:

Pharm-Olam Performs Clinical Trial Services in Kazakhstan, Expands Global Footprint to the Commonwealth of Independent States

Thursday, May 30, 2013

HOUSTON, TX – Pharm-Olam International Ltd. a multi-national, full service provider of outsourced development services to the pharmaceutical and biotech industries, announced its successful expansion of clinical trial services into Kazakhstan.